Close Menu

NEW YORK (GenomeWeb) – BioMérieux said today that its first quarter revenues rose 3 percent year over year, driven by an intense flu season and growth in the Asia Pacific region.

BioMérieux also announced today that it has submitted a 510(k) application to the US Food and Drug Administration for its BioFire FilmArray Pneumonia Panel.

For the three months ended March 31, the company reported revenues of €587 million ($726.6 million), up from €568 million in the prior-year period. At a constant exchange rates and scope of consolidation, revenues grew 13 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.